Correction: High-risk neuroblastoma stage 4 (NBS4): multi-target inhibitors for c-Src kinases (Csk) and retinoic acid (RA) signalling pathways

Correction to “High-risk neuroblastoma stage 4 (NBS4): multi-target inhibitors for c-Src kinases (Csk) and retinoic acid (RA) signalling pathways” by Gerges A and Canning U. Explor Drug Sci. 2025;3:1008109. DOI: 10.37349/eds.2025.1008109. The authors have recognized an error in the published paper. This correction does not affect the scientific content, interpretation of the results, or the conclusions of the paper. The authors apologize for any inconvenience caused to the readers by this error. The original uncorrected PDF can be accessed from https://www.explorationpub.com/uploads/1008109_1st.pdf.